MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis

Ann Rheum Dis. 2016 Aug;75(8):1486-93. doi: 10.1136/annrheumdis-2015-208011. Epub 2015 Oct 13.

Abstract

Objectives: To study the sequential relationship between MRI vertebral corner inflammation (VCI), vertebral corner fat deposition (VCFD) and the development/growth of radiographic syndesmophytes at the same vertebral corner (VC).

Methods: Baseline, 24 and 102 weeks spinal MRIs were assessed for the presence/absence of VCI and VCFD. Anterior VCs of lateral radiographs of the cervical and lumbar spine (baseline and 102 weeks) were assessed for the development of new bone (syndesmophyte formation or syndesmophyte formation/growth combined). Data from 161 to 177 patients were analysed at the VC level using two-way and multilevel analyses adjusting for within-patient correlation and MRI reader (generalised estimating equations for binomial outcomes).

Results: The presence of VCI (adjusted (adj) OR 1.75 to 1.98) as well as the presence of VCFD (adjOR 1.60 to 2.32) at any time point (TP) were significantly associated with the development of new bone. The combination of VCI and VCFD at the same VC increased the strength of the association, both for the sequential or simultaneous presence of VCI and VCFD across the three TPs (adjOR 2.12 to 2.73), as well as for the development of new VCFD preceded by VCI at a previous TP (adjOR 2.12 to 3.01). The complete absence of both VCI and VCFD across the three TPs 'protected' against new bone formation (adjOR 0.45 to 0.62). However, 40-66% of new bone still developed in VCs without MRI inflammation or fat degeneration at any of the three TPs.

Conclusions: Both VCI and VCFD contribute to new bone formation in ankylosing spondylitis (AS), especially if VCI precedes VCFD. However, VCI, VCFD and this particular sequence of events only partially explain the development of new bone in AS.

Keywords: Ankylosing Spondylitis; Inflammation; Magnetic Resonance Imaging; Outcomes research; Spondyloarthritis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adipose Tissue / diagnostic imaging
  • Adipose Tissue / pathology*
  • Adult
  • Antirheumatic Agents / therapeutic use
  • Disease Progression
  • Double-Blind Method
  • Female
  • Humans
  • Infliximab / therapeutic use
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Osteitis / diagnostic imaging
  • Osteitis / etiology*
  • Osteogenesis / physiology*
  • Radiography
  • Spine / diagnostic imaging*
  • Spine / pathology
  • Spine / physiopathology
  • Spondylitis, Ankylosing / complications*
  • Spondylitis, Ankylosing / diagnostic imaging
  • Spondylitis, Ankylosing / drug therapy
  • Spondylitis, Ankylosing / physiopathology

Substances

  • Antirheumatic Agents
  • Infliximab